Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical TrialLeticia Rosario Cruz, Aliusha Rittoles, Pablo Díaz et al.|ACS Pharmacology & Translational Science|2020Cited by 45
Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia. A Randomized and Controlled Clinical TrialLeticia Rosario Cruz, Idania Baladrón, Aliusha Rittoles et al.|medRxiv|2020Cited by 5